Monoclonal antibody treatment available for Chelsea residents

  1 / 2 
Chelsea Senior Living logo
  2 / 2 
Pat Banta, regional director of Health Services for Chelsea Senior Living
×
  1 / 2 
Chelsea Senior Living logo
  2 / 2 
Pat Banta, regional director of Health Services for Chelsea Senior Living

Chelsea Senior Living will be among the first assisted living companies in New Jersey to make on-site monoclonal antibody (mAb) treatments available to residents symptomatic with COVID-19.

This allows the affected residents to avoid a hospital trip while receiving a treatment that has been effective in reducing symptoms, according to information provided by Chelsea. MAb are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. They were given Emergency Use Authorization (EUA) by the Food and Drug Administration in November.

MAb therapy, given by infusion, is not a cure for COVID-19 and is not a substitute for the vaccine.

“The impact the mAb has had on our patients has been nothing short of remarkable,” John Hopkins, DO, CCS Healthcare, said in the statement. “This is a game changing medication in the fight against COVID. It truly saves lives.”

“While we have worked hard to minimize infection in our communities, we are still dealing with isolated outbreaks,” Pat Banta, BSN/MA, regional director of Health Services for Chelsea Senior Living, said in the statement. “Our partners at CCS Healthcare provide the monoclonal antibody infusion with expert monitoring during and after the infusion at the assisted living community to residents who have confirmed COVID-19 infection and who fit the criteria for therapy. It reduces the likelihood of developing severe illness requiring the need for hospitalization, can provide short term immunity and reduces the risk of infection transmission.”

Chelsea residents and staff are currently receiving the COVID vaccination at the company’s 21 residences in New Jersey and New York. However, screening, testing, masking and social distancing will continue into 2021.